SAN DIEGO--(BUSINESS WIRE)--Jan. 26, 2006--Ambit Biosciences today announced that Donald R. Myll has joined the company as Senior Vice President Commercial Operations and Chief Financial Officer. Myll brings to Ambit more than 19 years of successful leadership in the healthcare industry. The company also announced the appointment of Stephen Keane to the position of Vice President, Corporate Development.